title: T-cell post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: another case and a review of the literature.
authors.forename: L G
authors.initials: LG
authors.lastname: Lau
authors.forename: L K
authors.initials: LK
authors.lastname: Tan
authors.forename: M
authors.initials: M
authors.lastname: Salto-Tellez
authors.forename: E S C
authors.initials: ES
authors.lastname: Koay
authors.forename: T C
authors.initials: TC
authors.lastname: Liu
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000209:etiology*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D005047:Etoposide; D004317:Doxorubicin